Vascular smooth muscle cells (VSMC) are ideal for systemic gene therapy because of their proximity to blood vessels and they have demonstrated long-term exogenous gene expression in vivo. However, the procedure generally followed to seed the transduced VSMC onto arteries denuded of endothelial cells usually induces stenosis and thrombosis, with a consequent high risk for use in humans. We demonstrate here that the vascular adventitia is a suitable place to introduce transduced VSMC and to secrete therapeutic proteins into the blood stream by a simple procedure, avoiding postoperative vascular complications. Transduced VSMC, with the retroviral vectors carrying the human growth hormone gene (hGH), were seeded into the adventitia of the rat abdominal aorta by single injection of a cell suspension. Based on the hGH and anti-hGH production in serum and on histological analysis of the removed aortas, we demonstrated hGH production over the 2-month experimental period. None of the animals used in the experiment showed stenosis, thrombosis, or other vascular or visible physiological abnormalities.
INTRODUCTION
stenosis leading to impaired blood circulation (13, 19, 23, 25) . Despite the awareness of the severe conse-One of the main components of blood vessels in mass quences of vascular endothelium damage, animal experiis represented by smooth muscle cells (SMC), which ments using this method for gene transfer have been exist in multilayered form between monolayered endoattempted, taking into account the proximity of transthelium and adventitia. SMC are vital for vasculature planted cells to the blood vessel stream and assuming function and their abnormalities contribute to a range of that this fact might facilitate the easy release of secreted well-known vascular diseases (23) . Many attempts to proteins into the circulation. use retroviral vector-mediated gene transfer into the In an attempt to overcome arterial complications, SMC have been tested in animals to produce therapeutic prosthetic vascular grafts seeded with transduced autoloproteins in vivo, because conditions of cell culture and gous vascular SMC have been used as a new alternative. retroviral infection have been well established (3) . In In baboons, prosthetic polytetrafluoroethylene (PTFE) addition, transplanted SMC showed a long life, thus repseeded with SMC transduced with the β-galactosidase resenting a potential target for somatic gene therapy.
gene and implanted into the aorto-iliac circulation ex-Most experiments were performed by transduction of pressed the bacterial gene for up to 5 weeks (5). Besides, autologous SMC with reporter or therapeutic genes and in a rat model, vascular SMC expressing the erythroseeding them onto animal carotid arteries denuded of poietin (Epo) gene introduced into a PTFE chamber and endothelium by passage of a balloon catheter. In this placed under the serosa of the stomach increased the manner, long-term gene expression was observed with hematocrit and was able to maintain augmented over a intracellular and secreted proteins in rodents (3, 11, 13) .
12-month period (12). However, in the field of vascular However, this procedure is not feasible in humans surgery a variety of prosthetic vascular grafts have due to the severe complications that might follow, mainly shown limitations in the long run due to the induction related to carotid artery obstruction or even to a partial of a host inflammatory response and consequent loss of the vascular graft wall permeability (10,26). Further-production has been described in detail elsewhere (17) . Briefly, the vectors in plasmid form were transfected more, in view of the fact that abdominal aorta or any other main artery replacement with prosthetic vascular into the PE501 packaging cell, and the supernatants were used to infect the PA317 packaging cells. After grafts is considered to be a high-risk surgical procedure, this is not an acceptable routine procedure for the pur-selection with G418, the resistant colonies were isolated, expanded to generate clonal vector-producing cell lines, pose of gene therapy in humans except in severe lifethreatening conditions. and virus titer was determined (17) . The retroviral vector DChPMTGH with the hGH gene under the control of Looking for an ideal compartment and for long-lasting gene therapy, we thought that the vascular adventitia the human metallothionein promoter (hMT) was constructed by Dr. Mathor (15) and the amphotropic pack-could be a suitable compartment to seed genetically modified smooth muscle cells and possibly allow the aging cell clone Am12/DChPMTGH6d was kindly provided by Dr. Paolo Bartolini and Dr. Monica Beatriz secretion of therapeutic proteins. Considering that the tunica adventitia is the outermost fibrous coat of a vessel Mathor (IPEN, SP, Brazil), to be used exclusively in the present study with their permission. Briefly, hGH derived from surrounding connective tissue, and characterized by layers that detach under pressure, the adventi-cDNA with EcoRI and SmaI sites at 5′ and 3′ ends, respectively (1), was inserted into the pBluescript tia structure could shelter quite a large volume of cell suspension without leading to the extrinsic compression (Stratagene) using the same restriction sites (pBIGH). pHMTEIIa (9) was digested with NcoI, treated with S1 of the vessel wall. Besides, the blood supply of the tunica adventitia is nurtured by numerous small vessels nuclease and with Klenow fragment to make blunt end, and digested with HindIII to release a hMT fragment. called vasa vasorum (27) , with potential to deliver gene therapy products into the systemic circulation. In previ-
The hMT was cloned into the pBIGH opened with EcoRI and treated with Klenow fragment, and later, with ous reports, successful gene therapy studies have been carried out transferring into the adventitia by adenoviral HindIII. From this vector, a cassette of hMT-hGH was released with ApaI and BamHI digestion and introduced vectors (2, 20, 24) or adeno-associated viral vectors (14, 22) . In addition, vascular inflammation and neointimal into the N2A vector (6) linearized with ApaI and BglII (DChPMTGH). The vector DChPMTGH was used to formation could be avoided using the adventitial compartment (24) . Immunogold labeling by electron micros-make amphotropic packaging cell clone Am12/DChPM-TGH, following a similar procedure as described above. copy also has been used to demonstrate that the transgene is expressed in the adventitial fibroblasts (2) .
Cell Culture and Transduction Most studies using adventitial compartment were performed with viruses capable of infection in vivo. Trans-Ecotropic PE501 and amphotropic PA317 retrovirus packaging cell lines (16, 18) and NIH3T3/TK − cells (16) plantation of genetically modified cells into the adventitia has not been performed thus far.
were grown in Dulbecco's modified Eagle's medium (DMEM) with high glucose (4.5 g/L). Primary cultures We describe here successful transplantation of genetically modified vascular smooth muscle cells into the ad-of rat vascular smooth muscle cells were grown in Waymounth medium, both supplemented with 10% fetal bo-ventitial compartment of the abdominal aorta in rats, as an alternative procedure to express human growth hor-vine serum (FBS, Gibco), 200 U/ml penicillin, and 200 µg/ml streptomycin, in humidified 5% CO 2 at 37°C. mone (hGH). Long-term exogenous gene expression observed in this study suggests the potential application of A primary culture of rat smooth muscle cells was prepared as previously described (11), digesting the this technique to systemic gene therapy protocols.
Wistar isogenic rat aortas enzymatically. These cells
MATERIALS AND METHODS
were characterized immunocytochemically using anti-Retroviral Vectors bodies against α-actin (5) (Boehringer Mannheim) for SMC-positive staining and von Willebrand factor (5) Human growth hormone cDNA was obtained by digesting vector pHGH107 (purchased from ATCC, cata-(Boehringer Mannheim) for SMC negative-and endothelial cell-positive staining. Only early passage smooth log #31538) with EcoRI and SmaI to release a 600-bp DNA fragment. This fragment was ligated within the muscle cells were exposed for 24 h to virus harvested from PA317/LhGSN or Am12/DChPMTGH6d ampho-viral plasmid LXSN (18) previously digested with EcoRI and HpaI to provide the expression vector tropic virus-producing cell lines for a period of 24 h in the presence of Polybrene (8 µg/ml, Sigma) and selected LhGSN. In this vector, the human growth hormone gene is denoted by the letters hG and its expression is driven in geneticin antibiotic (1 mg/ml, Gibco) for about 2 weeks. Transduced and selected cells were expanded by the retroviral LTR promoter (L) and the neomycin resistance gene (N) is driven by the simian virus-40 and transplanted into rats according to the method described below. early promoter/enhancer (S) (7). The method of virus SMC Implantation secondary antibody. Sections were counterstained with hematoxylin and examined and photographed by stan-Under ether anesthesia, the abdominal portion of the dard light microscope (Nikon). aorta between the iliac artery and the renal artery was identified and dissected after a midline incision. Using
Rat Anti-hGH Determination a surgical microscope, 100 µl of SMC suspension in Antibodies raised against hGH produced in animals Waymounth medium was injected slowly into the space were quantified using rat serum prepared as described between the adventitia and muscular layer using an insuearlier. Initially, 50 µl of recombinant hGH (15 µg/ml lin syringe (13 × 0.4 mm needle) just above the bifurcain PBS, kindly provided by Dr Ramza El-Dorry, IQtion of the iliac artery. The injection site was com-USP) was used to adsorb to an ELISA plate for 1 h at pressed gently with a cotton swab for 1 min to avoid 37°C and nonspecific binding was blocked with 200 µl leakage. The abdominal cavity was closed in two layers of fat-free milk (5% in PBS) for 16 h at 4°C. Rat sera with separate sutures.
were diluted to 1:100 in wash buffer (PBS containing Animals used in our experiments received regular 0.1% Tween 20 and 0.25% gelatin) and 50 µl was added chow and water ad libitum during the period of experito each well and incubated for 1 h at 37°C. All experimentation.
ments were carried out in quadruplicate, a duplicate with wells adsorbed with hGH and a duplicate without ad-Determination of hGH sorption as a control. After incubation, wells were Production of hGH in rats was monitored in blood washed with washing buffer several times, and peroxiperiodically collected from the rat tail vein. Blood samdase-conjugated rat anti-IgG1 antibody (Sigma) diluted ples were left at room temperature for 1 h and centriin the wash buffer (1:1000) was added to each well and fuged (Eppendorf) at 3000 rpm for 5 min. Serum was left to stand for 1 h at 37°C. After washing the wells as transferred to a new Eppendorf tube and centrifuged described earlier, peroxidase activity was measured after again under the same conditions. The sera thus prepared reacting with o-phenylenediamine dihydrochloride were used to determine hGH concentration with a (Sigma) on the ELISA plate reader. DELFIA  -hGH kit (Wallac Oy, Finland) in the automated mode following instructions provided by the man-RESULTS ufacturer, in collaboration with the CRIESP laboratory Cell Culture, hGH Production, and Transplantation (São Paulo, Brazil).
After analyzing more than 50 amphotropic packaging Histology cell clones modified with the vector LhGSN (PA317/ LhGSN), we selected clone 50, which has a higher virus The aorta was removed for analysis under general anesthesia upon completion of the experiment. Aortas titer (1.3 × 10 6 cfu/ml) and also a high level of hGH production (398 ng/1 × 10 6 cells/24 h), to transduce rat pri-were washed in sterile saline solution to remove blood and dipped into 4% buffered formalin for 24-48 h at mary SMC. The clone Am12/DChPMTGH6d, which uses the human metallothionein promoter to drive the room temperature. After fixation, each fragment was dehydrated, incubated with absolute ethanol (4 times at 10 hGH gene, had 3 × 10 5 cfu/ml of virus titer, secreted 464 ng/1 × 10 6 cells/24 h of hGH without Zn 2+ activation. min each) and xylene (4 times at 10 min each), and paraffin embedded. Slices (3 µm thick) were cut and some Activation of the hMT promoter to increase hGH synthesis started at concentrations of Zn 2+ higher than 100 of them were stained with hematoxylin-eosin for standard histology; adjacent slices were prepared for immu-µM, with hGH concentration increasing twofold at 100 µM and fourfold at 200 µM on day 2 ( Fig. 1 ). nohystochemistry with anti-α-actin antibody.
To localize transplanted SMC in the vessel by immu-The rat primary SMC preparation reacted with the positive-staining anti-α-actin antibody and with the neg-nostaining, paraffin-embedded sections were deparaffinized in xylene, rehydrated in graded alcohols, and rinsed ative-staining von Willebrand factor showed purity of the smooth muscle cell culture when observed under the with PBS. To block internal peroxidase activity, sections were dipped in 6% hydrogen peroxide solution for confocal microscope (not shown). Only highly pure SMC preparations were used for transplantation into animals. 30 min. After rinsing several times with water and PBS, 0.015% porcine pancreatic type I trypsin (Sigma)
Transduced SMC with the retrovirus vector carrying the hGH gene and selected with G418 showed the same solution containing 0.18% CaCl 2 and 1 M phosphate buffer, pH 7.8, was left over the sections for 10 min range of hGH production as the packaging clones (not shown). Injection of a suspension of modified SMC into at 37°C to expose antigen epitopes. For SMC-specific immunostaining, mouse anti-α-actin antibody (1:600, the rat aorta using a surgical microscope was simple and easy. In dozens of animals tested, less than 5% of them Sigma) was used as a primary antibody and peroxidaseconjugated rabbit anti-mouse IgG (1:400, Sigma) as a had surgical complications, such as perforation of the suspension under the adventitial compartment, allowing the introduction of a significant volume of the inoculum. Animals sacrificed 1 to 2 months after surgery showed normal macroscopic appearance at the inoculated area, without peritoneal adhesions, hemorrhage, or signs of infection. The entire abdominal cavity was apparently normal except for a few cases of localized peritoneal adhesion to the abdominal wound.
Human Growth Hormone Gene Expression by Transplanted Smooth Muscle Cells
To determine the number of SMC/hPMTGH6d cells necessary to detect hGH in vivo we transplanted 1 × 10 6 to 8 × 10 6 cells into the rats and monitored hGH production (Fig. 2) . Twenty-four hours after surgery, all animals showed a peak of hGH production ranging from 50 to 400 pg/ml according to the number of transplanted cells. Blood hGH concentrations declined to basal levels after 7-10 days (<40 pg/ml), and hGH was occasionally detected thereafter over the 45 days of the experiment. Especially in rats 6 and 8, which received 4 and 8 mil- 2). We could see clearly that the hGH detection varied animals increased quickly between 7 and 10 days after surgery, coinciding with the time of hGH disappearance. The antibody titer was proportional to the number of aorta by the needle at the moment of inoculation leading to the leakage of blood or loss of a portion of the cell SMC/hPMTGH6d cells transplanted, and the slope of anti-hGH antibody reduction was similar for all animals, suspension into the blood stream by deep needle puncture transposing into the entire aorta wall. The loss of reaching the basal level in 2 weeks. After several replicates of the experiments we verified that the production injected cells can be easily detected by the absence of swelling of the adventitial compartment during the inoc-of hGH and anti-hGH antibody of transplanted animals showed about 30% variation. No animals received Zn 2+ ulation. Animals with such technical complications were eliminated and substituted. During the injection proce-during this experiment. As control of the experiment, Waymounth medium and normal SMC were each intro-dure, the adventitial compartment of the artery showed a marked distension along the abdominal aorta because duced in two rats, and production of hGH and anti-hGH was not observed (not shown). of the dissection of the subadventitial layer by the cell suspension volume under pressure. Only a few cases had
To verify the effect of metal ion Zn 2+ on the activation of human metallothionein promoter in vivo, 6 × 10 6 visible leakage, which was easily stopped by gentle compression. Following the inoculation, aortic pulse SMC/hPMTGH6d cells each were transplanted into five rats. During surgery and on postoperative days 2, 7, and was present in all animals without any other visible alterations for more than 30 min of observation. Animals 15, 0.8 µmol of Zn 2+ per 100 g body weight was injected into the tail vein of two rats (rat 1 and 2), and three sacrificed some days after surgery showed a healthy aspect of the artery, with complete disappearance of the other rats receiving no Zn 2+ were used as control ( Fig.  3 ). Two rats that received Zn 2+ showed no significant swelling of the adventitial compartment and absence of any signs of inflammatory reaction. Actually, the inocu-increase in hGH production 24 h after surgery. However, 1 day after the second administration of the ion, lated site appeared to be as normal as noninoculated segments of aorta.
hGH concentration increased to more than 400 pg/ml, whereas it decreased to 150 pg/ml in the control ani-We could observe that the accurate positioning of the needle into the subadventitial space and the speed of mals, as also seen in the early experiment (Fig. 2) . Seven days after surgery none of the animals showed hGH pro-cell suspension injection were very important to avoid leakage and also relevant to allow the spread of the cell duction, but the titer of anti-hGH antibody started to rise and reached a peak on day 9. Especially rats 1 and 2, maximum hGH production varied from rat to rat during a period of 7 days after surgery, permitting no conclu-treated with Zn 2+ , had higher titer than control rats. The antibody production decreased thereafter, and even the sion about the effect of the LTR promoter in stimulating hGH gene expression in vivo (not shown). For long-term injection of Zn 2+ on day 15 caused only a weak increase in antibody titer. The antibody titer was proportional to observation of hGH production by transplanted cells and for comparison with the rats carrying hGH under the hGH production, which was dependent on Zn 2+ administration. On day 15, 12 ng of recombinant hGH per 100 g control of hMT promoter, anti-hGH antibody production was monitored in 8 SMC/LhGSN transplanted rats ( Fig.  body weight was injected into the two control animals (rats 4 and 5). No hGH could be detected in the sera 4). In contrast to rats transplanted with SMC/hPMT-GH6d (Figs. 2 and 3) , all animals maintained high levels from the two animals thereafter, but after 7 days the titer of anti-hGH antibody began to rise as expected ( Fig. 3) .
of anti-hGH antibody during the 50 days of the experiment. Even though the antibody titer of rat 8 dropped To compare the influence of the retroviral long terminal repeat (LTR) promoter on the expression of the within a few days after peak production, the titer was still high and remained at the same level until the last hGH gene by our ex vivo gene expression procedure, rat smooth muscle cells were modified with the virus day, suggesting continuous hGH production in vivo.
During the 50 days of observation of the operated generated by the PA317/LhGSN-C50 clone. Peaks of hGH production by rats transplanted with 8 × 10 6 SMC/ animals, a notable difference in comparison with the rats transplanted with SMC/hPMTGH6d cells was the main-LhGSNC-50 ranged from 500 to 600 pg/ml, reached basal levels after 7 days, and were occasionally detected tenance of the production of anti-hGH antibody (Fig. 4) . Although antibody titer showed some variation among thereafter (not shown), as expected based on the early results (Fig. 2) . However, the time required to reach the experimental animals, the profile of its production was similar in all of them, suggesting continuous hGH artery other peripheral arteries can be easily assessed, by local anesthesia and use of microsurgical technique. production in vivo.
Perhaps even superficial peripheral veins could be used Histology to inject transduced cells, several times in several loci, Eight weeks after surgery, animals were sacrificed according to the amount of protein needed for effective and the abdominal portion of the aorta, where the gene therapy. smooth muscle cells were transplanted, was surgically
The range of hGH produced 24 h after SMC/ removed for histological analysis. Using the anti-SMC DChPMTGH transplantation, 50-400 pg/ml as a funcα-actin antibody, which is specific for smooth muscle tion of the number of cells transplanted, was similar to cells, the transplanted ones were localized and spread in the values obtained in vitro. Considering that the halfthe middle of the adventitia through the aorta, forming life of hGH in the rat is 4 min, like in the mouse (21), a new layer of SMC (Fig. 5) . When the entire area of an animal of 200 g (10 ml of blood per 100 g of body the cross-sectioned aorta was examined, about one third weight was considered for the calculation) transplanted of it showed immunostained cells. Vessel morphology with 1 × 10 6 cells that produce 400 ng of hGH over a of SMC/LhGSN transplanted animals appeared to be period of 24 h should maintain about 48 pg/ml of hGH normal compared with nontransplanted animals. The rats blood concentration. The experimentally determined transplanted with genetically unmodified SMC or Way-hGH concentration in rat blood serum after 24 h was mouth medium were not stained with the anti-SMC αvery close to this value, indicating that most of the cells actin antibody in any part of the adventitia (not shown).
introduced were well adapted and functionally active in the early stage of cell transplantation.
DISCUSSION
We used immunohistochemistry to verify cell adaptability ( Fig. 5) and to estimate the SMC remaining 2
The search for an ideal compartment in the host for transduced cells has been one of the major goals among months after transplantation. The transplanted SMC in the adventitia were well distinguished from the SMC of researchers looking for long-term effective gene therapy.
Smooth muscle cells have shown to be an excellent tar-the recipient muscle layer; the distribution of transplanted SMC through the vessel was variable from rat get for ex vivo gene therapy due to the easy preparation, transduction, and long-term survival (3, 11, 13) . How-to rat. Additionally, we could not determine if the transplanted SMC had proliferated in the vascular adventitia. ever, the SMC transplant procedure, based on the endothelial scraping of the carotid artery to allow the seeding The metallothionein promoter induced gene expression even without metal activation ( Fig. 1) and was of SMC, constitutes a highly traumatic maneuver and has resulted in carotid artery stenosis in the postopera-equivalent to the LTR promoter in respect to the LhGSN vector in vitro. However, after the peak of hGH produc-tive period with consequent paralysis or death (3, 13, 19) . Therefore, new and less aggressive methods are needed tion at 24 h, none of the animals transplanted with the SMC/DChPMTGH sustained their expression without for human gene therapy to be feasible.
Here we describe an alternative method to transplant metal activation, suggesting that the hMT promoter activation is essential to maintain hGH production in vivo. transduced SMC for the systemic delivery of proteins without causing vascular complications. The transplan-To keep the hMT promoter activated, zinc must be administered constantly to the animals. The range of zinc tation procedure is based on the preparation of the transduced SMC suspension and its injection into the subad-concentration for activation is limited ( Fig. 1 ) and also zinc clearance in plasma is fast (4, 8) . On the other hand, ventitial compartment of the rat abdominal aorta with an insulin syringe. Using microsurgical techniques, most of when long-term expression of hGH by LhGHSN was monitored, production of anti-hGH antibody was ob-the SMC transplantation could be performed easily without postoperative vascular complications. Only a small served throughout a 50 day follow-up. In animals transplanted with SMC/DChPMTGH, the antibody level percentage of the treated animals had minor technical problems during cell inoculation, such as aortic puncture dropped quickly, reaching the basal level within 1 week ( Figs. 2 and 3) , whereas the animals transplanted with with consequent hemorrhage into subadventitial space or injection of cells directly into the abdominal aorta blood SMC/LhGSN maintained a high antibody titer throughout the experiment (Fig. 4 ). This can be explained by a stream.
This means that in larger animals, the technical com-rat delayed-type hypersensitivity immune response against SMC secretion of human GH. In this study, plications might be easily avoided due to the larger size of the aorta, and also, we could surmise that cell suspen-monitoring of antibody titer for gene expression in vivo was a reasonable approach considering that anti-hGH sion inoculation be performed using laparoscopic surgical procedures. Besides, in larger animals or even in hu-antibody titer is specific and dependent on hGH. It is likely that secreted hGH reaches the main blood mans, the subadventitial compartment of cervical carotid 
